Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing reevaluation of Shen-Gu granule for osteoarthritis
ChiCTR2000031601Phase 4Not yet recruiting
- Sponsor
- Temporarily not sure
- Start
- Mar 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of shen-gu granule in osteoarthritis (OA), sponsored by Temporarily not sure. Primary endpoints: Related symptoms and signs, WOMAC questionnaire and 1 more. Planned start Mar 2020; status: not yet recruiting.
02
Drugs
shen-gu granule
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2000031601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000031601.